Showing 221 - 240 results of 741 for search '"Leukemia"', query time: 0.07s Refine Results
  1. 221

    Bacillus cereus Typhlitis in a Patient with Acute Myelogenous Leukemia: A Case Report and Review of the Literature by James D. Denham, Sowmya Nanjappa, John N. Greene

    Published 2018-01-01
    “…In this report, we describe a case of typhlitis caused by B. cereus in a 74-year-old female with recently diagnosed acute myelogenous leukemia (AML), and we summarize the available English language literature to draw tentative conclusions regarding the clinical manifestations of this organism.…”
    Get full text
    Article
  2. 222

    Evaluation of Selected Honey and One of Its Phenolic Constituent Eugenol against L1210 Lymphoid Leukemia by Saravana Kumar Jaganathan, Dilip Mondhe, Z. A. Wani, Eko Supriyanto

    Published 2014-01-01
    “…People affected with leukemia are on the rise and several strategies were employed to thwart this deadly disease. …”
    Get full text
    Article
  3. 223
  4. 224
  5. 225

    Age-Adjusted Schedules of Venetoclax and Hypomethylating Agents to Treat Extremely Elderly Patients with Acute Myeloid Leukemia by Aaron M. Lee, Aaron M. Goodman, James K. Mangan

    Published 2022-01-01
    “…Acute myeloid leukemia (AML) is associated with particularly poor outcomes in the elderly population, in whom the disease is most prevalent. …”
    Get full text
    Article
  6. 226

    Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib by Linlin Song, Qi Li, Hui Shi, Pengxia Zhang

    Published 2022-01-01
    “…Based on data mining, an innovative big data analysis platform was utilized to discuss the treatment of cancer in chronic myeloid leukemia (CML) by dasatinib, aiming to offer help to the diagnosis and treatment of cancer. …”
    Get full text
    Article
  7. 227

    Venetoclax added to CLAG regimen might improve the outcome of patients with relapsed/refractory acute myeloid leukemia by Yu Zhang, Zhao Yin, Zurong Yao, Dan Xu, Xuejie Jiang, Xiaqi Nie, Dandan Chen, Hongsheng Zhou, Pengcheng Shi, Hui Liu, Qifa Liu, Guopan Yu

    Published 2025-02-01
    “…Background: We aim to analyze the efficacy and safety of Venetoclax (Ven) added to cladribine + cytarabine + granulocyte colony-stimulating factor (G-CSF) ± idarubicin or mitoxantrone (CLAG ± Ida/Mito) regimen as a salvage treatment of relapsed/refractory acute myeloid leukemia (RR-AML). Methods: A single-center, retrospective, cohort study was performed. …”
    Get full text
    Article
  8. 228

    The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review by Sevastianos Chatzidavid, Christina-Nefeli Kontandreopoulou, Nefeli Giannakopoulou, Panagiotis T. Diamantopoulos, Christos Stafylidis, Marie-Christine Kyrtsonis, Maria Dimou, Panayiotis Panayiotidis, Nora-Athina Viniou

    Published 2024-01-01
    “…Epigenetic regulation has been thoroughly investigated in recent years and has emerged as an important aspect of chronic lymphocytic leukemia (CLL) biology. Characteristic aberrant features such as methylation patterns and global DNA hypomethylation were the early findings of the research during the last decades. …”
    Get full text
    Article
  9. 229

    Retinal and Preretinal Hemorrhages in a Patient Receiving Hyper-CVAD Chemotherapy for T-Cell Acute Lymphoblastic Leukemia by Krishi Peddada, Stephanie J. Weiss, Shaina Kumar, Deepika Malik

    Published 2018-01-01
    “…Hyperfractionated cyclophosphamide, vincristine, adriamycin, and dexamethasone (Hyper-CVAD) is an important chemotherapeutic regimen for acute lymphoblastic leukemia (ALL) and non-Hodgkin’s lymphoma. We present a case of a 23-year-old male with T-cell ALL and visual acuity of 20/20 in the right eye and 20/25 in the left eye who developed significant changes in his vision after starting Hyper-CVAD therapy. …”
    Get full text
    Article
  10. 230
  11. 231

    Lipopolymers as the Basis of Non-Viral Delivery of Therapeutic siRNA Nanoparticles in a Leukemia (MOLM-13) Model by Panadda Yotsomnuk, Amarnath Praphakar Rajendran, Daniel Nisakar Meenakshi Sundaram, Luis Carlos Morales, Cezary Kucharski, Mohammad Nasrullah, Wanwisa Skolpap, Xiaoyan Jiang, Spencer B. Gibson, Joseph Brandwein, Hasan Uludağ

    Published 2025-01-01
    “…Small interfering RNA (siRNA) therapy in acute myeloid leukemia (AML) is a promising strategy as the siRNA molecule can specifically target proteins involved in abnormal cell proliferation. …”
    Get full text
    Article
  12. 232

    Experience in the management of patients with HTLV-1 positive adult T-cell leukemia/lymphoma in a Latin American center by Danielle Floyd-Aristizábal, Cristian Alonso Barreiro García, Oriana Arias-Valderrama, Catalina Proaño Millán, Nhora María Silva Perez, Joaquín Donaldo Rosales Martinez, Elizabeth Arrieta López

    Published 2025-02-01
    “…Background: Adult T-cell leukemia/lymphoma (ATL) is a neoplasm with a high prevalence in certain regions such as southwestern Japan, the Caribbean, sub-Saharan Africa, South America, and Australia. …”
    Get full text
    Article
  13. 233
  14. 234

    Profil Penderita Leukemia Mieloblastik Akut di Bagian Penyakit Dalam RSUP Dr. M. Djamil Padang by Bayu Rahmadin, Irza Wahid, Rismawati Yaswir

    Published 2018-02-01
    “…Jenis leukemia yang paling umum ditemukan pada orang dewasa adalah leukemia mieloblastik akut. …”
    Get full text
    Article
  15. 235

    Integrative analysis of ATAC-seq and RNA-seq for cells infected by human T-cell leukemia virus type 1. by Azusa Tanaka, Yasuhiro Ishitsuka, Hiroki Ohta, Norihiro Takenouchi, Masanori Nakagawa, Ki-Ryang Koh, Chiho Onishi, Hiromitsu Tanaka, Akihiro Fujimoto, Jun-Ichirou Yasunaga, Masao Matsuoka

    Published 2025-01-01
    “…Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy (HAM) after a long latent period in a fraction of infected individuals. …”
    Get full text
    Article
  16. 236
  17. 237
  18. 238

    Increased Body Mass Index during Therapy for Childhood Acute Lymphoblastic Leukemia: A Significant and Underestimated Complication by Helen C. Atkinson, Julie A. Marsh, Shoshana R. Rath, Rishi S. Kotecha, Hazel Gough, Mandy Taylor, Thomas Walwyn, Nicholas G. Gottardo, Catherine H. Cole, Catherine S. Choong

    Published 2015-01-01
    “…We undertook a retrospective review of children diagnosed with acute lymphoblastic leukemia (ALL) and treated with modern COG protocols (n=80) to determine longitudinal changes in body mass index (BMI) and the prevalence of obesity compared with a healthy reference population. …”
    Get full text
    Article
  19. 239
  20. 240